PPARG and neoplasm: Consistent with previous observations that PPARγ agonists usually inhibit the proliferation of tumor cells, we found that treatment with 15d-PGJ2, a natural endogenous ligand of PPARγ, significantly inhibited cell proliferation in all examined HCC cell lines (Figure 1A).